FR143166 attenuates spinal pain transmission through activation of the serotonergic system

European Journal of Pharmacology

Volumn 452, Issue 3, 2002, Pages 319-324

  Ochi, Takehiro ^a   Ohkubo, Yoshitaka ^a   Mutoh, Seitaro ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

5 HT2A receptor; 5 HT3 receptor; Antinociception; Descending serotonergic system; FR143166; Spinal cord

Indexed keywords

1 (4 FLUOROPHENYL) 3 METHYL 5 [4 (METHYLSULFINYL)PHENYL]PYRAZOLE; 4 AMINO 5 CHLORO 2 METHOXYBENZOIC ACID 2 (DIETHYLAMINO)ETHYL ESTER; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; ADRENERGIC RECEPTOR BLOCKING AGENT; ANTINOCICEPTIVE AGENT; BEMESETRON; FENCLONINE; FR 143166; KETANSERIN; METHYSERGIDE; MORPHINE; OXIDOPAMINE; PHENTOLAMINE; PROPRANOLOL; SEROTONIN 2A RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; MALE; MAXIMUM PERMISSIBLE DOSE; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; TAIL FLICK TEST;

ANALGESICS; ANIMALS; MALE; MICE; PAIN MEASUREMENT; PYRAZOLES; RECEPTORS, SEROTONIN; SEROTONIN; SPINAL CORD;

EID: 0037064305     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02334-8     Document Type: Article

References (36)

1. Bardin L., Schmidt J., Alloui A., Eschalier A. Effect of intrathecal administration of serotonin in chronic pain models in rats. Eur. J. Pharmacol. 409:2000;37-43.
2. Eide P.K., Hole K. Interactions between serotonin and substance P in the spinal regulation of nociception. Brain Res. 550:1991;225-230.
3. Fitzgerald M. Monoamines and descending control of nociception. Trends Neurosci. 9:1986;51-52.
4. Fozard J.R. MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 326:1984;36-44.
5. 2A-adrenoceptors. Jpn. J. Pharmacol. 82:2000;130-137.
6. Giordano J. Analgesic profile of centrally administered 2-methylserotonin against acute pain in rats. Eur. J. Pharmacol. 199:1991;233-236.
7. Haley T.J., McCormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. 12:1957;12-15.
8. Hong Y., Abbott F.V. Behavioural effects of intraplantar injection of inflammatory mediators in the rat. Neuroscience. 63:1994;827-836.
9. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P.A. VII. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46:1994;157-203.
10. Hylden J.L.K., Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67:1980;313-316.
11. Inoue A., Hashimoto T., Hide I., Nishio H., Nakata Y. 5-Hydroxytryptamine-facilitated release of substance P from rat spinal cord slices is mediated by nitric oxide and cyclic GMP. J. Neurochem. 68:1997;128-133.
12. Iverfeldt K., Peterson L., Brodin E., Ögren S., Bartfai T. Serotonin type-2 receptor mediated regulation of substance P release in the ventral spinal cord and the effects of chronic antidepressant treatment. Naunyn-Schmiedeberg's Arch. Pharmacol. 333:1986;1-6.
13. Jessell T.M., Iversen L.L. Opiate analgesics inhibit substance P release from rat trigeminal nucleus. Nature. 268:1977;549-551.
14. Kawabata A., Kasamatsu K., Umeda N., Takagi H. The noradrenaline precursor L-threo-3,4-dihydroxyphenylserine exhibits antinociceptive activity via central α-adrenoceptors in the mouse. Br. J. Pharmacol. 111:1994;503-508.
15. Kuraishi Y., Hirota N., Sugimoto M., Satoh M., Takagi H. Effects of morphine on noxious stimuli-induced release of substance P from rabbit dorsal horn in vivo. Life Sci. 33(Suppl. I):1983;693-696.
16. Kuraishi Y., Harada Y., Aratani S., Satoh M., Takagi H. Separate involvement of the spinal noradrenergic and serotonergic systems in morphine analgesia: the differences in mechanical and thermal algesic tests. Brain Res. 273:1983;245-252.
17. Litchfield J.T. Jr., Wilcox F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:1949;99-113.
18. Matsumoto K., Mizowaki M., Suchitra T., Murakami Y., Takayama H., Sakai S., Aimi N., Watanabe H. Central antinociceptive effects of mitragynine in mice: contribution of descending noradrenergic and serotonergic systems. Eur. J. Pharmacol. 317:1996;75-81.
19. 2A receptor antagonist, is peripheral. Eur. J. Pharmacol. 404:2000;95-102.
20. 2 agonists in rats with nerve ligation. Pain. 90:2001;173-179.
21. 3 receptors. Eur. J. Pharmacol. 409:2000;167-172.
22. 2-adrenoceptors. Eur. J. Pharmacol. 400:2000;199-203.
23. Ochi T., Goto T. The spinal antinociceptive effect of FR140423 in mice: involvement of the descending noradrenergic and serotonergic systems. Life Sci. 69:2001;2257-2264.
24. Ochi T., Fujii T., Motoyama Y., Goto T. The profile of FR140423, a novel anti-inflammatory compound, in yeast-induced rat hyperalgesia. Jpn. J. Pharmacol. 81:1999;94-98.
25. Pasternak G.W. Pharmacological mechanisms of opioid analgesics. Clin. Neuropharmacol. 16:1993;1-18.
26. Rang H.P., Urban L. New molecules in analgesia. Br. J. Anaesth. 75:1995;145-156.
27. 3 receptors on the modulation of nociceptive transmission in rat spinal cord according to the formalin test. Eur. J. Pharmacol. 424:2001;45-52.
28. Takagi H. The nucleus reticularis paragigantocellularis as a site of analgesic action of morphine and enkephalin. Trends Pharmacol. Sci. 1:1980;182-184.
29. Takagi H., Inukai T., Nakama M. A modification of Haffner's method for testing analgesics. Jpn. J. Pharmacol. 16:1966;287-294.
30. Takano Y., Yaksh T.L. Characterization of the pharmacology of intrathecally administered alpha-2 agonists and antagonists in rats. J. Pharmacol. Exp. Ther. 261:1992;764-772.
31. 1/2 receptors in both normal and diabetic mice. Br. J. Pharmacol. 116:1995;3133-3138.
32. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol. 231:1971;232-235.
33. Wigdor S., Wilcox G.L. Central and systemic morphine-induced antinociception in mice: contribution of descending serotonergic and noradrenergic pathways. J. Pharmacol. Exp. Ther. 242:1987;90-95.
34. Yaksh T.L., Wilson P.R. Spinal serotonin terminal system mediates antinociception. J. Pharmacol. Exp. Ther. 208:1979;446-453.
35. Yonehara N., Shibutani T., Imai Y., Ooi Y., Sawada T., Inoki R. Serotonin inhibits release of substance P evoked by tooth pulp stimulation in trigeminal nucleus caudalis in rabbits. Neuropharmacology. 30:1991;5-13.
36. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.